NASDAQ:ILMN - Nasdaq - US4523271090 - Common Stock - Currency: USD
94.2
-3 (-3.09%)
The current stock price of ILMN is 94.2 USD. In the past month the price decreased by -30.1%. In the past year, price decreased by -29.17%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TMO | THERMO FISHER SCIENTIFIC INC | 24.36 | 203.70B | ||
DHR | DANAHER CORP | 28.07 | 151.18B | ||
A | AGILENT TECHNOLOGIES INC | 25.59 | 38.62B | ||
IQV | IQVIA HOLDINGS INC | 17.15 | 33.64B | ||
MTD | METTLER-TOLEDO INTERNATIONAL | 31.26 | 26.91B | ||
WAT | WATERS CORP | 31.58 | 22.26B | ||
ICLR | ICON PLC | 14.39 | 16.63B | ||
WST | WEST PHARMACEUTICAL SERVICES | 31.25 | 15.27B | ||
RVTY | REVVITY INC | 23.23 | 13.85B | ||
AVTR | AVANTOR INC | 17.3 | 11.78B | ||
TEM | TEMPUS AI INC | N/A | 10.72B | ||
MEDP | MEDPACE HOLDINGS INC | 26.94 | 10.37B |
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 10,590 full-time employees. The company went IPO on 2000-06-28. Its products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its product categories include Instruments, Kits & Reagents, Selection Tools, and Software & Analysis. Its Instruments category include sequencing platforms, microarray scanners, and IVD instruments. Its Kits & Reagents category consists of library preparation kits, sequencing reagents, microarray kits, clinical research products, and IVD products. Its Selection Tools category include Library Prep & Array Kit Selector, Gene Panel & Array Finder, DesignStudio Custom Assay Designer, and other. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training. The company is also a developer of an emerging and highly differentiated single-cell technology.
ILLUMINA INC
5200 Illumina Way
San Diego CALIFORNIA 92122 US
CEO: Francis A. deSouza
Employees: 10615
Company Website: https://www.illumina.com
Investor Relations: https://investor.illumina.com
Phone: 18582024500
The current stock price of ILMN is 94.2 USD. The price decreased by -3.09% in the last trading session.
The exchange symbol of ILLUMINA INC is ILMN and it is listed on the Nasdaq exchange.
ILMN stock is listed on the Nasdaq exchange.
32 analysts have analysed ILMN and the average price target is 165.5 USD. This implies a price increase of 75.69% is expected in the next year compared to the current price of 94.2. Check the ILLUMINA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ILLUMINA INC (ILMN) has a market capitalization of 14.94B USD. This makes ILMN a Large Cap stock.
ILLUMINA INC (ILMN) currently has 10615 employees.
ILLUMINA INC (ILMN) has a resistance level at 136.54. Check the full technical report for a detailed analysis of ILMN support and resistance levels.
The Revenue of ILLUMINA INC (ILMN) is expected to grow by 1.5% in the next year. Check the estimates tab for more information on the ILMN EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ILMN does not pay a dividend.
ILLUMINA INC (ILMN) will report earnings on 2025-04-30, after the market close.
The PE ratio for ILLUMINA INC (ILMN) is 38.45. This is based on the reported non-GAAP earnings per share of 2.45 and the current share price of 94.2 USD. Check the full fundamental report for a full analysis of the valuation metrics for ILMN.
The outstanding short interest for ILLUMINA INC (ILMN) is 4.12% of its float. Check the ownership tab for more information on the ILMN short interest.
ChartMill assigns a fundamental rating of 4 / 10 to ILMN. ILMN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months ILMN reported a non-GAAP Earnings per Share(EPS) of 2.45. The EPS increased by 181.61% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -26.34% | ||
ROE | -74.54% | ||
Debt/Equity | 0.94 |
ChartMill assigns a Buy % Consensus number of 76% to ILMN. The Buy consensus is the average rating of analysts ratings from 32 analysts.
For the next year, analysts expect an EPS growth of 88.3% and a revenue growth 1.5% for ILMN